Cargando…

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

Most migraine patients with infrequent attacks are currently not treated with migrainespecific medication such as triptans. The response of these patients to triptans is unknown. The objective of this study was to investigate the efficacy and tolerability of sumatriptan 50 mg vs. placebo in migraine...

Descripción completa

Detalles Bibliográficos
Autores principales: Tfelt-Hansen, P., Bach, F. W., Daugaard, D., Tsiropoulos, I., Riddersholm, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452229/
https://www.ncbi.nlm.nih.gov/pubmed/17164991
http://dx.doi.org/10.1007/s10194-006-0333-z

Ejemplares similares